NCT01394341 Liraglutide Treatment to Patients With Severe Renal Insufficiency Status COMPLETED Phase PHASE4
NCT01392677 Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea Status COMPLETED Phase PHASE3
NCT01387737 Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01386541 Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01381926 Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist Status TERMINATED Phase PHASE4
NCT01378117 Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01376557 Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin Status COMPLETED Phase PHASE2
NCT01374568 Changes in Bone Turnover With Increased Incretin Hormone Exposure Status TERMINATED Phase PHASE4
NCT01373450 Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222) Status COMPLETED Phase PHASE1
NCT01369602 Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532 Status COMPLETED Phase PHASE1
NCT01365091 Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil Status COMPLETED Phase PHASE1
NCT01357252 Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01357135 An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201) Status COMPLETED Phase N/A
NCT01357109 Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01356381 Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4